COVID-19 exposes India’s dependence on China for active pharma ingredients
India imports around 90 per cent of APIs used to make antibiotics, says an expert
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
COVID-19: Centre brings package to boost bulk drugs
Indian pharma industry is critically dependent on imported raw material
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively